Towards a blood-stage vaccine for malaria: are we following all the leads?
about
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparumThe evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudiGenetics of susceptibility to human infectious diseaseEngineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granulesSimilarity searches in genome-wide numerical data setsInduction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.Construction of transgenic Plasmodium berghei as a model for evaluation of blood-stage vaccine candidate of Plasmodium falciparum chimeric protein 2.9.Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites.Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.Impairment of protective immunity to blood-stage malaria by concurrent nematode infection.posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.Malaria vaccine development and how external forces shape it: an overview.Efficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis.The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malariaImmunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.Inhibition of T cell function during malaria: implications for immunology and vaccinology.Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasitesConservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individualsLong-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.The immunological challenge to developing a vaccine to the blood stages of malaria parasites.Does malaria suffer from lack of memory?Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.Ficolin-A Enhances Inhibition of the C-Terminal 19 kDa Region of Merozoite Surface Protein-1 of Plasmodium berghei Using Test In Vivo.A Novel Malaria Pf/Pv Ab Rapid Diagnostic Test Using a Differential Diagnostic Marker Identified by Network Biology.Effect of malaria transmission reduction by insecticide-treated bed nets (ITNs) on the genetic diversity of Plasmodium falciparum merozoite surface protein (MSP-1) and circumsporozoite (CSP) in western Kenya.Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New GuineaImmunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-142 (MSP-142).Lack of an association between antibodies to Plasmodium falciparum glycosylphosphatidylinositols and malaria-associated placental changes in Cameroonian women with preterm and full-term deliveries.A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.The immunological balance between host and parasite in malaria.Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.Prospects for a vaccine against malaria.Evaluation of recombinant Plasmodium knowlesi merozoite surface protein-1(33) for detection of human malaria.A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.CD36 c.1264 T>G null mutation impairs acquisition of IgG antibodies to Plasmodium falciparum MSP1₁₉ antigen and is associated with higher malaria incidences in Tanzanian children.Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients.
P2860
Q21128645-99AB943A-CCD7-40CF-AB03-C46CD2F2AED8Q27318798-2FEC3953-01B4-46B7-A2A3-8303FB03D96DQ28208872-A760CC3B-D9EC-4FFA-B595-7DC05D8EBA24Q28744199-D78E8D71-E6E6-410A-ACEA-8E0FAF2BF4D8Q30477519-AF9E17A1-31D8-497D-9C50-F7BC39CA63A9Q30783460-DA502147-3DB8-4227-95BD-B360C9D7C328Q33499694-94B438E8-B3AE-4B5C-9FB1-0D41A2966780Q33653151-F41366F7-99C5-4AD7-A798-6B59955147E1Q33756139-41A75397-CA4A-44F7-8800-A61D6EEB62FDQ33769200-8AADDE7B-BFA5-40C1-A216-F6D02360C2FFQ33788143-72B7143B-D25C-4396-908E-AC7F67A69451Q33883252-17EE1615-727E-4DA3-B8E1-C59C4B534799Q33963746-0FB680F5-2473-4300-8DE0-5681C24D30EBQ34548672-43A4595C-7F0C-47EC-8C72-A866F717C8B4Q34807622-FC754ED4-252E-4FAC-8DEC-07D6679B3BDBQ34975629-F402B1B1-AF4B-4842-B0BC-A955141903B1Q35049876-3D85D8F2-C7F9-49D2-9EFE-12F925FA6D56Q35051549-CAAA8A12-265B-4872-B435-C375707A2A96Q35551115-1C6AA70B-8D0B-4D49-B774-4D3E7C7AFB1AQ35569042-0ED0BE00-D7CF-45AF-8B41-CD3BBB7A9774Q35606249-68107E2C-1602-409C-AD8E-CDA1E2F30AFDQ35783529-263C64F0-684D-489E-B78A-36C1DE2A0528Q35801755-2ECC7240-C5D6-4379-BB89-CE5F7A968018Q35884247-1D24DD8D-E37B-46F8-996F-6C751A1DCA53Q35884250-30C862F0-B91F-4F41-BCA2-6493F5B9A00AQ35945359-FB149F32-FDF1-4FC3-90BA-35174B509C44Q36847612-53CD21B3-BD13-4FB0-9EC4-B8F28D27158FQ37012137-2C4197DD-A69B-4FE7-806A-AE6B029AF867Q37153165-25F0AECF-0D99-4599-B259-E42B6A6B2BE9Q37256445-419F77A6-5647-401B-90F2-BFC8982E946FQ37425845-C293D912-5872-49DF-9353-6A7ADC3A6009Q37521633-03E28B54-F924-4BE3-A04C-CC489BEFA86DQ37522910-EC02DD31-7296-4C4C-A7F9-1E5361D63341Q38666558-137690F1-DE53-41EB-AFA2-7A13F648EE2CQ40303478-FF744741-4BE0-4B9E-A0FA-4FA226531235Q40646800-A7ABE9F1-059A-417E-8D58-62EC049F9D8BQ41985489-F63DA38D-A948-4E51-BC05-38FA22D2AC8DQ42581710-241B6BE9-EF73-43CF-977E-C3A718B3CA7FQ43939727-ECF8A13A-EAB9-4270-B342-A8AC57A2F915Q44174178-9A8A863A-AAB9-4EA3-AC57-4536384A8C68
P2860
Towards a blood-stage vaccine for malaria: are we following all the leads?
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Towards a blood-stage vaccine for malaria: are we following all the leads?
@ast
Towards a blood-stage vaccine for malaria: are we following all the leads?
@en
Towards a blood-stage vaccine for malaria: are we following all the leads?
@nl
type
label
Towards a blood-stage vaccine for malaria: are we following all the leads?
@ast
Towards a blood-stage vaccine for malaria: are we following all the leads?
@en
Towards a blood-stage vaccine for malaria: are we following all the leads?
@nl
prefLabel
Towards a blood-stage vaccine for malaria: are we following all the leads?
@ast
Towards a blood-stage vaccine for malaria: are we following all the leads?
@en
Towards a blood-stage vaccine for malaria: are we following all the leads?
@nl
P2860
P356
P1476
Towards a blood-stage vaccine for malaria: are we following all the leads?
@en
P2860
P2888
P304
P356
10.1038/35100540
P577
2001-11-01T00:00:00Z
P6179
1034156374